Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus

Table 2 Tumor-node-metastasis stage and clinical type of the study population n (%)

Variable	Total patients (n = 375)	HCC patients with diabetes (n = 63)	HCC patients without diabetes (n = 312)	P value
T stage
T1	82 (21.9)	15 (23.8)	67 (21.5)	0.683
T2	90 (24.0)	19 (30.2)	71 (22.8)	0.210
T3a	157 (41.9)	22 (34.9)	135 (43.3)	0.221
T3b	37 (9.9)	6 (9.5)	31 (9.9)	0.920
T4	9 (2.4)	1 (1.6)	8 (2.6)	0.991
N stage
N0	334 (89.1)	57 (90.5)	277 (88.8)	0.694
N1	41 (10.9)	6 (9.5)	35 (11.2)	-
M stage
M0	269 (71.7)	49 (77.8)	220 (70.5)	0.243
M1	106 (28.3)	14 (22.2)	92 (29.5)	-
Clinical classification
Massive	213 (56.8)	29 (46.0)	184 (59.0)	0.059
Nodular	117 (31.2)	22 (34.9)	95 (30.4)	0.485
Small-cancer	28 (7.5)	8 (12.7)	20 (6.4)	0.142
Diffuse	17 (4.5)	4 (6.3)	13 (4.2)	0.503

HCC: Hepatocellular carcinoma; T: Tumor; N: Node; M: Metastasis.